Back to top

Image: Bigstock

Zacks.com featured highlights DRDGOLD, GeneDx, EverQuote, HCI Group and Alibaba

Read MoreHide Full Article

For Immediate Release

Chicago, IL – March 19, 2025 – Stocks in this week’s article are DRDGOLD Ltd. (DRD - Free Report) , GeneDx Holdings Corp. (WGS - Free Report) , EverQuote Inc. (EVER - Free Report) , HCI Group Inc. (HCI - Free Report) and Alibaba Group Holding Ltd. (BABA - Free Report) .

5 Stocks with Recent Price Strength Amid Extreme Volatility

U.S. stock markets have been enduring severe volatility over the past month. Wall Street’s recent turmoil is broad-based. The three major stock indexes — the Dow, the S&P 500 and the Nasdaq Composite — are in the negative territory year to date. The S&P 500 and the Nasdaq Composite are in fact, in a correction zone. Moreover, the mid-cap-centric S&P 400 is in the red and the small-cap benchmark Russell 2000 is in bear territory, year to date.

Market participants remained concerned about the Trump administration’s tariff and trade-related policies and their impact on U.S. economic growth, especially on the inflation rate. Recently released several key economic data have clearly shown that the U.S. economy is weakening.

The resilient labor market has shown softness. The last released data for retail sales, industrial production, manufacturing PMI, housing sector data and consumer confidence and sentiment indexes came in well below expectations.

Consequently, a handful of stocks have shown price strength. We have primarily targeted stocks that have recently been on a bull run. Such stocks have a high chance of carrying the momentum forward.

Five such stocks are — DRDGOLD Ltd., GeneDx Holdings Corp., EverQuote Inc., HCI Group Inc. and Alibaba Group Holding Ltd.

If a stock is continuously witnessing an uptrend, there must be a solid reason or it would have probably crashed. So, looking at stocks capable of beating the benchmark that they have set for themselves seems rational.

However, recent price strength alone cannot create magic. Therefore, other relevant parameters are needed to create a successful investment strategy.

Here’s how you should create the screen to shortlist the current as well as the potential winners.

Let’s discuss five out of these 11 stocks here:

DRDGOLD Is a gold mining company, engaged in the extraction of gold from the retreatment of surface mine tailings in South Africa. DRD sells gold and silver bullion. DRD is involved in provision care and maintenance services, and operation of training center. Incontrovertibly bullish about its product, DRD recently concluded the extensive refocusing of its gold interests.

The stock price of DRDGOLD has jumped 34.6% in the past four weeks. It has an expected earnings growth rate of 29.3% for the current year (ending June 2025). The Zacks Consensus Estimate for current-year earnings has improved 19.1% over the past 30 days.

GeneDx Holdings is a genomics company that provides genetic testing services. WGS primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. WGS is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets.

The stock price of GeneDx Holdings has climbed 29% in the past four weeks. The company has expected earnings growth of more than 100% for the current year. The Zacks Consensus Estimate for the current-year earnings has improved 86.5% over the past 30 days.

EverQuote should continue to benefit from its exclusive data asset and technology, intensified focus on core P&C markets, streamlined operations and a strong financial profile that poise it for long-term growth. Solid performances at automotive and other insurance verticals, given auto carrier recovery and growth in revenue per quote request, bode well.

EVER expects to benefit from the shift to online insurance sales. EVER remains focused on the growth of consumer traffic and the addition of channels. EVER expects revenues between $155 million and $160 million for the first quarter of 2025.

The stock price of EverQuote has surged 22.7% in the past four weeks. The company has expected earnings growth of 34.1% for the current year. The Zacks Consensus Estimate for the current year earnings has improved 45.7% over the past 30 days.

HCI Group is a holding company that conducts its business activities through its subsidiaries. HCI is engaged in diverse business activities, including property and casualty insurance, information technology, real estate and reinsurance.

HCI provides property and casualty insurance. HCI’s insurance product includes property and casualty homeowners’ insurance, condominium-owners' insurance and tenants’ insurance for individuals owning property.

HCI’s shares have rallied 16.9% in the past four weeks. It has an expected earnings growth rate of more than 100% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 12.4% over the past 30 days.

Alibaba Group Holding third-quarter fiscal 2025 results benefited from the monetization of Taobao and Tmall Group, cloud businesses and AI-integrated products. BABA is riding on strong momentum in its international commerce retail business, driven by strength in AliExpress’ Choice.

The growing international commerce wholesale business, thanks to strength in cross-border-related value-added services, is a tailwind. Expanding China's wholesale commerce business is a positive for BABA. Robust local consumer services and Cainiao logistics services are further driving the top-line growth of BABA.

The stock price of Alibaba advanced 13.1% in the past four weeks. The company has expected earnings growth of 23.1% for the next year (ending March 2026). The Zacks Consensus Estimate for next-year earnings has improved 5.8% over the past 30 days.

You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2431204/5-stocks-with-recent-price-strength-amid-extreme-volatility

Follow us on Twitter:  https://www.twitter.com/zacksresearch

Join us on Facebook:  https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto

Company: Zacks.com

Phone: 312-265-9268

Email: pr@zacks.com

Visit: https://www.zacks.com/

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Published in